Member Info for laserbrain

Additional: couldn't find any info on who owns Alpha-Diggers Inc, but it's a recently formed special purpose vehicle.

I have no insider info (despite living in PH), but check out the latest RNS from BMV. Same N. Luzon region as Runruro, and they have plenty of cash.

12.8% since I bought my stack in 2017. VAT and CGT free, of course,

LOL. I remember Sunjammer from NGL days. That didn't work out so well. Let's hope this is better.

Just gone thru, but cost me 13.4p

OMI is on pause, for sure. Market is down; gold is down, yet I can't even buy 10,000 shares this AM. Only 6 trades showing as I type.

The greater depression, IMO. I'm out of the market; others should ensure they have enough cash to take advantage of what may be a lifetime opportunity, months or years from now.

Does anyone know what happened to it?

Need to detect it first.

https://www.dailystar.co.uk/health/breakthrough-prostate-cancer-treatment-nhs-31596366

Apologies if posted before.

Suppose you have a test that has 100% sensitivity but only 50% specificity. Then, assuming 1% actually have cancer, your test positives are 10k plus 495k. It's no use for screening, but this test has specificity of 97%. It's useful for mass screening and would save a lot of money in late cancer treatments

I've not seen anyone mention this, but the true value of this test is not in its high sensitivity. It's the high specificity of 97% that makes this worth billions. A high sensitivity is only useful for suspected cancer., but a high specificity allows routine screening.

E.g. 1 million men over 50 are tested. With a specificity of 97% 970,000 of them can be eliminated from further expensive screening.

Treeshake. I've been watching the trades. Consistantly at or even above the offer.

Just about every man above 50 will want this test annually. Another up day today is baked in, methinks. Ready to add on any significant drop though.

I get the same 'feelin'. Tho, I'm not quite sure what it means. Have they cracked it, or not? From the the RNS, it sounds like they haven't, and have just found a way of speeding the 'cracking' process. Looking forward to some info here.

Thanks for those replies. Yes, the dilution is significant and ongoing. Any opinions as to why Artemic isn't listed on their website? The website itself doesn't inspire my confidence tbh, but lack of their leading product is downright odd.

I would appreciate an answer to this also. And yes, I am a new (potential) investor.

Also, why the steady drop in SP? Seems they are making good progress from the RNS's. (I've been thru them all)

I say! Our Deidre is a bit hot.

FDS snowed under?

https://www.londonstockexchange.com/news-article/GSK/extension-of-fda-review-period-for-momelotinib/16001854

Looks promising. Took a small stake here.

So, 38% sensitivity and 46% specificity. CIZ is in the 90's for both.